Check out the companies making headlines in the midday trading: Tech Stocks – Megacap Technology name stocks fell after the first acquired in investor optimism that the US would reach deals with other countries to reduce tariffs. Apple, which lost about 20% in the last three days considering China’s exposure, ended about 5% lower after gaining more than 3% at noon. Others like Nvidia and Tesla also reversed the course after moving forward by nearly 6% and 5% respectively. Nvidia closed 1.4% lower, while Tesla ran 4.9%. Major health insurance stocks have flew after the Centers for UnitedHealth Group in Humana – Medicare and Medicaid Services announced a higher than expected increase due to government payments for Medicare Advantage plans. UnitedHealth shares rose 5.4%, while Humana shares rose 10.7%. Wells Fargo – After climbing nearly 4% early in the session, bank stocks moved slightly lower. Piper Sandler upgraded Wells Fargo from Neutral to overweight and said the bank giant’s stock has an attractive rating that properly captured the company’s improved fate. Broadcom – Chip shares rose 1.2% after the company approved a $10 billion stock repurchase program through the end of 2025. The approval announcement “reflects the board’s trust in the strength of Broadcom’s diversified semiconductor and infrastructure software product franchise,” Hock Tan said in a statement. Marvell Technology – Stocks have pulled 1.9% above noon, following the company’s agreement to sell its automated Ethernet business to Infineon Technologies on all $2.5 billion cash transactions. The transaction is expected to close within 2025. Lockheed Martin – Shares rose 2.9% amid wider advancements in defense companies after President Donald Trump pledged a full-year defense budget of $1 trillion. Janover – Stocks fell 12.9%, turning the course from over 800% meetings in the previous session after the software company announced its cryptocurrency strategy focusing on Solana Token. Janover will also be revising its name and ticker symbol. Charles Schwab – Financial inventory ended 0.2% lower after moving from equal weight to overweight right after Morgan Stanley upgrades 4.5% on trading day forward 4.5%. Morgan Stanley said he prioritizes brokers with defensive revenue streams and singular drivers for revenue growth. Eli Lilly – Pharma shares added 0.4% after Goldman Sachs took on name compensation in the purchase rating. Analyst Asad Haider said he is seeing “persuasive entry points” for stocks at the current level. GREENBRIER – The railroad car manufacturer lost 11.4% after a significant reduction in its revenue guidance for the year. Greenbrier currently expects revenues of between $3.15 billion and $33.5 million against guidance of $3.35 billion to $3.35 billion. TILRAY Brand – Stocks plummeted 21.2% after recording a weaker third quarter results than expected. Tilray reported an adjusted EBITDA of $9 million, below the $9.7 million expected by analysts voted by Factset. Due to net revenue, the company recorded $185.8 million. Similarly, consensus estimates are below $210 million. Tilray also narrowed its full-year forecast. – CNBC’s Alex Hurling, Jesse Pound, Sarah Minh, Yun Lee, Lisa Kailay Han and Michelle Fox reported.